| scholarly article | Q13442814 |
| P50 | author | Paola Viganò | Q38641751 |
| Ana Maria Sanchez | Q57314353 | ||
| P2093 | author name string | M Candiani | |
| P Panina-Bordignon | |||
| A Mugione | |||
| P2860 | cites work | Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors | Q24554356 |
| Cannabinoid ligand-receptor signaling in the mouse uterus | Q24562819 | ||
| Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications | Q24623541 | ||
| 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2+-dependent and -independent mechanisms | Q28275316 | ||
| Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides | Q28295481 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Cannabinoids as novel anti-inflammatory drugs | Q33688381 | ||
| Presence and functional regulation of cannabinoid receptors in immune cells | Q33720122 | ||
| Peroxisome proliferator-activated receptor-(gamma) receptor ligand partially prevents the development of endometrial explants in baboons: a prospective, randomized, placebo-controlled study | Q33772312 | ||
| Mechanistic and therapeutic implications of angiogenesis in endometriosis. | Q33779409 | ||
| A call for more transparency of registered clinical trials on endometriosis. | Q33917982 | ||
| The fatty acid amide hydrolase (FAAH). | Q34098981 | ||
| Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis | Q34228308 | ||
| Endocannabinoid involvement in endometriosis. | Q34274062 | ||
| Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. | Q34358271 | ||
| Inverse agonism and neutral antagonism at cannabinoid CB1 receptors | Q34388049 | ||
| Pharmacology of cannabinoid CB1 and CB2 receptors. | Q34442847 | ||
| A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells | Q34506693 | ||
| Endocannabinoids and cannabinoid receptor genetics | Q34641465 | ||
| The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications | Q35122796 | ||
| The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice. | Q35168199 | ||
| The endocannabinoid system and cancer: therapeutic implication | Q35193299 | ||
| Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease. | Q35475372 | ||
| The endocannabinoid system: a general view and latest additions | Q35639524 | ||
| The endocannabinoid system and its therapeutic exploitation | Q35876026 | ||
| Jekyll and hyde: two faces of cannabinoid signaling in male and female fertility | Q36472111 | ||
| Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial | Q36839274 | ||
| The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor | Q37180660 | ||
| Emerging strategies for exploiting cannabinoid receptor agonists as medicines | Q37230665 | ||
| Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists | Q37244823 | ||
| Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation | Q37382150 | ||
| Endometriosis: current therapies and new pharmacological developments. | Q37465188 | ||
| Endocannabinoids: friends and foes of reproduction | Q37551302 | ||
| Endometriosis and mechanisms of pelvic pain | Q37616272 | ||
| Antitumorigenic effects of cannabinoids beyond apoptosis | Q37627459 | ||
| Endocannabinoids and pregnancy | Q37715021 | ||
| Endocannabinoid biosynthesis and inactivation, from simple to complex | Q37715385 | ||
| Rimonabant inhibits TNF-α-induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway | Q37729882 | ||
| Gene expression profiling of peripheral blood mononuclear cells in endometriosis identifies genes altered in non-gynaecologic chronic inflammatory diseases. | Q38332570 | ||
| Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium | Q38521873 | ||
| 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis | Q39276875 | ||
| Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1. | Q39774517 | ||
| The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells | Q39775715 | ||
| Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma | Q39908335 | ||
| Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. | Q40002514 | ||
| Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor | Q40577679 | ||
| Effects of 9-ene-tetrahydrocannabinol on expression of beta-type transforming growth factors, insulin-like growth factor-I and c-myc genes in the mouse uterus | Q42288929 | ||
| Differential expression of cannabinoid CB(2) receptor mRNA in mouse immune cell subpopulations and following B cell stimulation | Q42507150 | ||
| Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. | Q42553964 | ||
| PTEN: sometimes taking it off can be better than putting it on. | Q43104730 | ||
| Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle | Q43108843 | ||
| Endocannabinoid system regulates migration of endometrial stromal cells via cannabinoid receptor 1 through the activation of PI3K and ERK1/2 pathways. | Q43123372 | ||
| 17betaE2 promotes cell proliferation in endometriosis by decreasing PTEN via NFkappaB-dependent pathway | Q43236964 | ||
| Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation | Q43560303 | ||
| Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta | Q43846473 | ||
| Effects of 9-ene-tetrahydrocannabinol on uterine estrogenicity in the mouse | Q44114840 | ||
| Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction | Q44497133 | ||
| Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes | Q44807851 | ||
| Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness | Q46257564 | ||
| Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice | Q46322918 | ||
| The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway | Q46448219 | ||
| Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants | Q47983467 | ||
| Fatty-acid amide hydrolase is expressed in the mouse uterus and embryo during the periimplantation period | Q48233864 | ||
| Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. | Q50944132 | ||
| Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis. | Q54599251 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endometriosis | Q205764 |
| cannabinoids | Q422936 | ||
| P304 | page(s) | 563-571 | |
| P577 | publication date | 2012-08-24 | |
| P1433 | published in | Molecular Human Reproduction | Q15761794 |
| P1476 | title | The molecular connections between the cannabinoid system and endometriosis | |
| P478 | volume | 18 |
| Q27005854 | Avicenna's Canon of Medicine: a review of analgesics and anti-inflammatory substances |
| Q64230606 | Decreased Expression of Cannabinoid Receptors in the Eutopic and Ectopic Endometrium of Patients with Adenomyosis |
| Q39989926 | Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis |
| Q64122503 | New Insights of Uterine Leiomyoma Pathogenesis: Endocannabinoid System |
| Q38598498 | The Clinical Significance of Endocannabinoids in Endometriosis Pain Management |
| Q39207452 | The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis |
| Q38119393 | The motile and invasive capacity of human endometrial stromal cells: implications for normal and impaired reproductive function. |
| Q46292310 | Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos |
Search more.